As with many CHD cohorts in general, the variety of CHDs with MYOM2 mutations in the PCGC study was very wide, comprising complex heterotaxias, such as double outlet RV, as well as isolated simple atrial and ventricular septal defects (Jin et al., 2017). The gene discussed is MYOM2; the disease is ventricular septal defect.